These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 19786963)

  • 1. The neurobiology of D-amino acid oxidase and its involvement in schizophrenia.
    Verrall L; Burnet PW; Betts JF; Harrison PJ
    Mol Psychiatry; 2010 Feb; 15(2):122-37. PubMed ID: 19786963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-amino acid oxidase activity is inhibited by an interaction with bassoon protein at the presynaptic active zone.
    Popiolek M; Ross JF; Charych E; Chanda P; Gundelfinger ED; Moss SJ; Brandon NJ; Pausch MH
    J Biol Chem; 2011 Aug; 286(33):28867-28875. PubMed ID: 21700703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice.
    Labrie V; Wang W; Barger SW; Baker GB; Roder JC
    Genes Brain Behav; 2010 Feb; 9(1):11-25. PubMed ID: 19751394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential pathophysiological role of D-amino acid oxidase in schizophrenia: immunohistochemical and in situ hybridization study of the expression in human and rat brain.
    Ono K; Shishido Y; Park HK; Kawazoe T; Iwana S; Chung SP; Abou El-Magd RM; Yorita K; Okano M; Watanabe T; Sano N; Bando Y; Arima K; Sakai T; Fukui K
    J Neural Transm (Vienna); 2009 Oct; 116(10):1335-47. PubMed ID: 19685198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-amino acid oxidase knockdown in the mouse cerebellum reduces NR2A mRNA.
    Burnet PW; Anderson PN; Chen L; Nikiforova N; Harrison PJ; Wood MJ
    Mol Cell Neurosci; 2011 Jan; 46(1):167-75. PubMed ID: 20828614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Searching for cognitive enhancement in the Morris water maze: better and worse performance in D-amino acid oxidase knockout (Dao(-/-)) mice.
    Pritchett D; Taylor AM; Barkus C; Engle SJ; Brandon NJ; Sharp T; Foster RG; Harrison PJ; Peirson SN; Bannerman DM
    Eur J Neurosci; 2016 Apr; 43(7):979-89. PubMed ID: 26833794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant mice and rats lacking D-amino acid oxidase.
    Konno R; Hamase K; Maruyama R; Zaitsu K
    Chem Biodivers; 2010 Jun; 7(6):1450-8. PubMed ID: 20564563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. d-amino acid oxidase knockout (Dao(-/-) ) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption.
    Pritchett D; Hasan S; Tam SK; Engle SJ; Brandon NJ; Sharp T; Foster RG; Harrison PJ; Bannerman DM; Peirson SN
    Eur J Neurosci; 2015 May; 41(9):1167-79. PubMed ID: 25816902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-Amino acids in the brain and mutant rodents lacking D-amino-acid oxidase activity.
    Yamanaka M; Miyoshi Y; Ohide H; Hamase K; Konno R
    Amino Acids; 2012 Nov; 43(5):1811-21. PubMed ID: 22892863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Serine metabolism in C6 glioma cells: Involvement of alanine-serine-cysteine transporter (ASCT2) and serine racemase (SRR) but not D-amino acid oxidase (DAO).
    Sikka P; Walker R; Cockayne R; Wood MJ; Harrison PJ; Burnet PW
    J Neurosci Res; 2010 Jun; 88(8):1829-40. PubMed ID: 20091774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Target Engagement and D-Serine Biomarker Profiles of the D-Amino Acid Oxidase Inhibitors Sodium Benzoate and PGM030756.
    Howley E; Bestwick M; Fradley R; Harrison H; Leveridge M; Okada K; Fieldhouse C; Farnaby W; Canning H; Sykes AP; Merchant K; Hazel K; Kerr C; Kinsella N; Walsh L; Livermore DG; Hoffman I; Ellery J; Mitchell P; Patel T; Carlton M; Barnes M; Miller DJ
    Neurochem Res; 2017 Nov; 42(11):3279-3288. PubMed ID: 28780732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes.
    Sacchetti E; Scassellati C; Minelli A; Valsecchi P; Bonvicini C; Pasqualetti P; Galluzzo A; Pioli R; Gennarelli M
    BMC Med Genet; 2013 Mar; 14():33. PubMed ID: 23497497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia.
    Abou El-Magd RM; Park HK; Kawazoe T; Iwana S; Ono K; Chung SP; Miyano M; Yorita K; Sakai T; Fukui K
    J Psychopharmacol; 2010 Jul; 24(7):1055-67. PubMed ID: 19329549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia.
    Corvin A; Donohoe G; McGhee K; Murphy K; Kenny N; Schwaiger S; Nangle JM; Morris D; Gill M
    Neurosci Lett; 2007 Oct; 426(2):97-100. PubMed ID: 17890006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal NMDA receptor function and expression are altered in a mouse lacking D-amino acid oxidase.
    Gustafson EC; Morgans CW; Tekmen M; Sullivan SJ; Esguerra M; Konno R; Miller RF
    J Neurophysiol; 2013 Dec; 110(12):2718-26. PubMed ID: 24068757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.
    Labrie V; Clapcote SJ; Roder JC
    Pharmacol Biochem Behav; 2009 Feb; 91(4):610-20. PubMed ID: 18940194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and biochemical characterization of a mutant mouse strain lacking D-amino acid oxidase activity and its implications for schizophrenia.
    Almond SL; Fradley RL; Armstrong EJ; Heavens RB; Rutter AR; Newman RJ; Chiu CS; Konno R; Hutson PH; Brandon NJ
    Mol Cell Neurosci; 2006 Aug; 32(4):324-34. PubMed ID: 16843004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels.
    Yamada K; Ohnishi T; Hashimoto K; Ohba H; Iwayama-Shigeno Y; Toyoshima M; Okuno A; Takao H; Toyota T; Minabe Y; Nakamura K; Shimizu E; Itokawa M; Mori N; Iyo M; Yoshikawa T
    Biol Psychiatry; 2005 Jun; 57(12):1493-503. PubMed ID: 15953485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-terminal region of G72 increases D-amino acid oxidase activity.
    Chang SL; Hsieh CH; Chen YJ; Wang CM; Shih CS; Huang PW; Mir A; Lane HY; Tsai GE; Chang HT
    Int J Mol Sci; 2013 Dec; 15(1):29-43. PubMed ID: 24362575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral characterization of a mutant mouse strain lacking D-amino acid oxidase activity.
    Zhang M; Ballard ME; Basso AM; Bratcher N; Browman KE; Curzon P; Konno R; Meyer AH; Rueter LE
    Behav Brain Res; 2011 Feb; 217(1):81-7. PubMed ID: 20933022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.